Expanding organic farming and agricultural lands in the EU is at the heart of the European Green Deal’s initiatives. Organic farming uses natural substances and processes to produce food and brings environmental, economic and social benefits.

To support European green ambitions, the European Commission launched the Farm to Fork Strategy in 2020. One of its aims is to bolster organic food sales and production with a focus on a fair and sustainable supply chain. This initiative was reinforced through the Organic Action Plan which seeks to achieve 25% of organic agricultural land by 2030. However, currently, only 10% of EU agricultural land is organic.

Organic farming is more labour-intensive and produces lower yields than conventional farmers, while generating similar income. Despite receiving economic support through the CAP, organic farmers feel they remain inadequately remunerated because their selling prices are lower than the retail prices.

While the EU seeks to boost organic farming and food supply, some stakeholders argue that the EU needs a more robust implementation to transition towards fair and organic food systems. Others believe that the text on new genomic technologies (NGTs) approved by the European Parliament could help reach the target on organic agricultural lands.

Join this Euractiv Virtual Conference to discuss the sustainability of organic farming and its implications for reaching European green ambitions. Questions to be addressed include:

• How can the EU strengthen the position of organic farmers in the supply chain?
• How can the gap between organic produce selling prices and retail prices be addressed?
• How compatible are the NGTs and organic farming in light of the target for agricultural lands set by the European Commission?
• What steps are needed to further develop organic food supply and demand?

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.

Nuclear power is seen as part of the solution to tackle climate change and meet growing energy needs to decarbonise our economy. Following the Nuclear Energy Summit, jointly organised by the IAEA and Belgium on March 21, 2024, EDF, Fortum, and Vattenfall, in partnership with Euractiv, are preparing an insightful event. We will delve into the central role of nuclear energy, in partnership with renewable energy technologies, in achieving the European Union’s climate, social, and strategic objectives. The event will explore the need for a neutral approach to net-zero technologies, and define the key steps that the nuclear industry will have to take to achieve these goals. Taking up this significant challenge includes the need to inspire and cultivate emerging talent. We should motivate them to eagerly pursue a career path in net zero technologies, contributing to a greener future. Do not miss this opportunity to contribute to shaping the future of net zero energy and making a positive impact on the world. Nuclear Energy 2.0 is more than just a conference. It is an exploration of the next phase in the evolution of the European energy landscape. Get ready for an interactive debate on the potential of nuclear energy!

For the last three decades, the availability of cost-effective generic medicines has driven increased access to life-saving treatments for millions of patients in Europe. Today, generic medicines are an integral part of the healthcare system and demand for these products continues to increase worldwide.

While increased usage of generic medicines has led to unprecedented savings for healthcare systems, many perspectives on this segment remain focused solely on their cost saving potential. This perception can underplay the range of generic medicine contributions to added societal value. Neglecting these contributions can exacerbate the challenges that healthcare systems are facing today.

A case where generic medicines contribute to societal value is by ensuring access, thus helping to reduce disease burden in underserved markets, such as in most Central and Eastern European (CEE) countries.

The report “Beneath the Surface: Unravelling the True Value of Generic Medicines” presented in this online panel explores the broad spectrum of contributions of generic medicines to European health systems, through an examination of their critical role in increasing access, financial sustainability, supply chain resilience and better outcomes for patients.

During this event, panellists and the audience will exchange ideas on:

• Creating a regulatory environment that promotes access.
• The functioning of national markets in ensuring the availability and sustainability of medicines for patients.
• Coordination at European and National levels to mitigate shortages.
• Supporting innovation to achieve better health outcomes.